Skip to main content

Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women

Endocrine volume 48, pages 533–540 (2015)Cite this article

Abstract

To explore serum vaspin, leptin, and adiponectin levels and their correlation with insulin resistance (IR) in pregnant women with and without gestational diabetes mellitus (GDM) and healthy non-pregnant women. A total of 262 individuals, including pregnant women with GDM (n = 86), those without GDM (n = 92), and age-matched healthy non-pregnant women (n = 84) were enrolled in this case–control study. Vaspin, leptin, adiponectin, glucose, insulin, hemoglobin A1C (HbA1c), and lipid parameters were measured. The homeostasis model assessment–insulin resistance (HOMA–IR), quantitative insulin sensitivity check index, and body mass index were calculated. Data inferred higher concentrations of vaspin (2.72 ± 2.20 vs. 1.84 ± 1.57 vs. 0.81 ± 1.02) in GDM than during normal pregnancy and in non-pregnant women, higher leptin (23.42 ± 12.18 vs. 22.19 ± 10.55 vs. 12.10 ± 11.26), and lower adiponectin (4,164.83 ± 2,650.39 vs. 4,871.66 ± 2,803.51 vs. 7,202.85 ± 4,893.13) in GDM and normal pregnancy as compared to non-pregnant women (p < 0.05). Vaspin was positively correlated to leptin (r = 0.273, p = 0.012), HOMA–IR (r = 0.387, p = 0.000), and triglycerides (TG, r = 0.218, p = 0.046) in GDM. In addition, leptin was negatively correlated to adiponectin in GDM (r = −0.336, p = 0.002) and normal pregnancy (r = −0.256, p = 0.014). Furthermore, vaspin was significantly correlated to GDM and HOMA–IR, and the weight gain might play a vital role in the occurrence of GDM. During pregnancy, high vaspin concentration is significantly associated with IR in GDM.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1

References

  1. L. Bellamy, J.P. Casas, A.D. Hingorani, D. Williams, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373, 1773–1779 (2009)

    Article  CAS  PubMed  Google Scholar 

  2. P. Kalra, C.P. Kachhwaha, H.V. Singh, Prevalence of gestational diabetes mellitus and its outcome in western Rajasthan. Indian J. Endocrinol. Metab. 17, 677–680 (2013)

    Article  PubMed Central  PubMed  Google Scholar 

  3. D. Dabelea, J.K. Snell-Bergeon, C.L. Hartsfield, K.J. Bischoff, R.F. Hamman, R.S. McDuffie, Kaiser Permanente of Colorado GDM Screening Program: increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28, 579–584 (2005)

    Article  PubMed  Google Scholar 

  4. L.A. Barbour, C.E. McCurdy, T.L. Hernandez, J.P. Kirwan, P.M. Catalano, J.E. Friedman, Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30, S112–S119 (2007)

    Article  CAS  PubMed  Google Scholar 

  5. A. Lapolla, M.G. Dalfrà, G. Mello, E. Parretti, R. Cioni, C. Marzari, M. Masin, A. Ognibene, G. Messeri, D. Fedele, A. Mari, G. Pacini, Early detection of insulin sensitivity and beta-cell function with simple tests indicates future derangements in late pregnancy. J. Clin. Endocrinol. Metab. 93, 876–880 (2008)

    Article  CAS  PubMed  Google Scholar 

  6. M. Blüher, A. Rudich, N. Klöting, R. Golan, Y. Henkin, E. Rubin, D. Schwarzfuchs, Y. Gepner, M.J. Stampfer, M. Fiedler, J. Thiery, M. Stumvoll, I. Shai, Two patterns of adipokine and other biomarker dynamics in a long-term weight loss intervention. Diabetes Care 35, 342–349 (2012)

    Article  PubMed Central  PubMed  Google Scholar 

  7. Z. Goktas, N. Moustaid-Moussa, C.L. Shen, M. Boylan, H. Mo, S. Wang, Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front. Endocrinol. (Lausanne) 4, 69 (2013)

    Google Scholar 

  8. K. Miehle, H. Stepan, M. Fasshauer, Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin. Endocrinol. (Oxf). 76, 2–11 (2012)

    Article  CAS  PubMed  Google Scholar 

  9. R. Retnakaran, A.J. Hanley, N. Raif, P.W. Connelly, M. Sermer, B. Zinman, Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27, 799–800 (2004)

    Article  CAS  PubMed  Google Scholar 

  10. D. Cortelazzi, S. Corbetta, S. Ronzoni, F. Pelle, A. Marconi, V. Cozzi, I. Cetin, R. Cortelazzi, P. Beck-Peccoz, A. Spada, Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. (Oxf). 66, 447–453 (2007)

    Article  CAS  PubMed  Google Scholar 

  11. K.Y. Lain, A.R. Daftary, R.B. Ness, J.M. Roberts, First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin. Endocrinol. (Oxf). 69, 407–411 (2008)

    Article  PubMed  Google Scholar 

  12. K. Rabe, M. Lehrke, K.G. Parhofer, U.C. Broedl, Adipokines and insulin resistance. Mol. Med. 14, 741–751 (2008)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. G. Murdolo, M. Piroddi, F. Luchetti, C. Tortoioli, B. Canonico, C. Zerbinati, F. Galli, L. Iuliano, Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance. Biochimie 95, 585–594 (2013)

    Article  CAS  PubMed  Google Scholar 

  14. K. Bergmann, G. Sypniewska, Diabetes as a complication of adipose tissue dysfunction. Is there a role for potential new biomarkers? Clin. Chem. Lab. Med. 51, 177–185 (2013)

    Article  CAS  PubMed  Google Scholar 

  15. M. Blüher, Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41, 176–182 (2012)

    Article  PubMed  Google Scholar 

  16. B.S. Youn, N. Klöting, J. Kratzsch, N. Lee, J.W. Park, E.S. Song, K. Ruschke, A. Oberbach, M. Fasshauer, M. Stumvoll, M. Blüher, Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57, 372–377 (2008)

    Article  CAS  PubMed  Google Scholar 

  17. B.K. Tan, D. Heutling, J. Chen, S. Farhatullah, R. Adya, S.D. Keay, C.R. Kennedy, H. Lehnert, H.S. Randeva, Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57, 1501–1507 (2008)

    Article  CAS  PubMed  Google Scholar 

  18. E. Herrera, H. Ortega-Senovilla, Disturbances in lipid metabolism in diabetic pregnancy—are these the cause of the problem? Best. Pract. Res. Clin. Endocrinol. Metab. 24, 515–525 (2010)

    Article  CAS  PubMed  Google Scholar 

  19. S.H. Choi, S.H. Kwak, Y. Lee, M.K. Moon, S. Lim, Y.J. Park, H.C. Jang, M.S. Kim, Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin. Endocrinol. (Oxf). 75, 628–635 (2011)

    Article  CAS  PubMed  Google Scholar 

  20. H.S. Cura, H.H. Ozdemir, C.F. Demir, S. Bulut, N. Ilhan, M.F. Inci, Investigation of vaspin level in patients with acute ischemic stroke. J. Stroke Cerebrovasc. Dis. 23, 453–456 (2014)

    Article  PubMed  Google Scholar 

  21. C. von Loeffelholz, M. Möhlig, A.M. Arafat, F. Isken, J. Spranger, K. Mai, H.S. Randeva, A.F. Pfeiffer, M.O. Weickert, Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur. J. Endocrinol. 162, 507–513 (2010)

    Article  Google Scholar 

  22. S. Akbarzadeh, I. Nabipour, S.M. Jafari, A. Movahed, N. Motamed, M. Assadi, N. Hajian, Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 95, 132–138 (2012)

    Article  CAS  PubMed  Google Scholar 

  23. A. Gkiomisi, K.G. Makedou, A.D. Anastasilakis, S.A. Polyzos, A. Kourtis, S. Gerou, E. Gavana, T. Dagklis, D. Rousso, C. Giannoulis, Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum. Cytokine 61, 127–132 (2013)

    Article  CAS  PubMed  Google Scholar 

  24. H. Stepan, S. Kralisch, K. Klostermann, S. Schrey, C. Reisenbüchler, M. Verlohren, H.J. Verlohren, K. Drynda, M. Blüher, M. Stumvoll, J. Kratzsch, P. Kovacs, M. Fasshauer, Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia. Metabolism 59, 1054–1056 (2010)

    Article  CAS  PubMed  Google Scholar 

  25. K. Li, L. Li, M. Yang, H. Liu, D. Liu, H. Yang, G. Boden, G. Yang, Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity. Eur. J. Endocrinol. 164, 905–910 (2011)

    Article  CAS  PubMed  Google Scholar 

  26. S. Teshigawara, J. Wada, K. Hida, A. Nakatsuka, J. Eguchi, K. Murakami, M. Kanzaki, K. Inoue, T. Terami, A. Katayama, I. Iseda, Y. Matsushita, N. Miyatake, J.F. McDonald, K. Hotta, H. Makino, Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J. Clin. Endocrinol. Metab. 97, E1202–E1207 (2012)

    Article  CAS  PubMed  Google Scholar 

  27. HAPO Study Cooperative Research Group, B.E. Metzger, L.P. Lowe, A.R. Dyer, E.R. Trimble, U. Chaovarindr, D.R. Coustan, D.R. Hadden, D.R. McCance, M. Hod, H.D. McIntyre, J.J. Oats, B. Persson, M.S. Rogers, D.A. Sacks, Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358, 1991–2002 (2008)

    Article  Google Scholar 

  28. H.M. Chang, H.J. Lee, H.S. Park, J.H. Kang, K.S. Kim, Y.S. Song, Y.J. Jang, Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance. Obesity 18, 2105–2110 (2010)

    Article  CAS  PubMed  Google Scholar 

  29. K. Hida, J. Wada, J. Eguchi, H. Zhang, M. Baba, A. Seida, I. Hashimoto, T. Okada, A. Yasuhara, A. Nakatsuka, K. Shikata, S. Hourai, J. Futami, E. Watanabe, Y. Matsuki, R. Hiramatsu, S. Akagi, H. Makino, Y.S. Kanwar, Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl. Acad. Sci. USA 102, 10610–10615 (2005)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. M.M. Roca-Rodríguez, C. López-Tinoco, A. Fernández-Deudero, M. Murri, M.V. García-Palacios, M.A. García-Valero, F.J. Tinahones-Madueño, M. Aguilar-Diosdado, Adipokines and metabolic syndrome risk factors in women with previous gestational diabetes mellitus. Diabetes Metab. Res. Rev. 28, 542–548 (2012)

    Article  PubMed  Google Scholar 

  31. N. Klöting, P. Kovacs, M. Kern, J.T. Heiker, M. Fasshauer, M.R. Schön, M. Stumvoll, A.G. Beck-Sickinger, M. Blüher, Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 54, 1819–1823 (2011)

    Article  PubMed  Google Scholar 

  32. C. Qiu, M.A. Williams, S. Vadachkoria, I.O. Frederick, D.A. Luthy, Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet. Gynecol. 103, 519–525 (2004)

    Article  CAS  PubMed  Google Scholar 

  33. S. Liu, Y. Dong, T. Wang, S. Zhao, K. Yang, X. Chen, C. Zheng, Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells. Diabetes Res. Clin. Pract. 103, 482–488 (2014)

    Article  CAS  PubMed  Google Scholar 

  34. A. Giomisi, A. Kourtis, K.A. Toulis, A.D. Anastasilakis, K.G. Makedou, M. Mouzaki, S. Gerou, E. Gavana, T. Agorastos, C. Giannoulis, Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur. J. Endocrinol. 164, 579–583 (2011)

    Article  CAS  PubMed  Google Scholar 

  35. J.G. Ray, H. Berger, L.L. Lipscombe, M. Sermer, Gestational prediabetes: a new term for early prevention? Indian J. Med. Res. 132, 251–255 (2010)

    PubMed  Google Scholar 

  36. C. Sommer, K. Mørkrid, A.K. Jenum, L. Sletner, A. Mosdøl, K.I. Birkeland, Weight gain, total fat gain and regional fat gain during pregnancy and the association with gestational diabetes: a population-based cohort study. Int. J. Obes. (Lond). 38, 76–81 (2014)

    Article  CAS  Google Scholar 

  37. A.E. Ruifrok, M.N. van Poppel, M. van Wely, E. Rogozińska, K.S. Khan, C.J. de Groot, S. Thangaratinam, B.W. Mol, Association between weight gain during pregnancy and pregnancy outcomes after dietary and lifestyle interventions: a meta-analysis. Am. J. Perinatol. 31, 353–364 (2014)

    CAS  PubMed  Google Scholar 

  38. M.P. Malee, A. Verma, G. Messerlian, R. Tucker, B.R. Vohr, Association between maternal and child leptin levels 9 years after pregnancy complicated by gestational diabetes. Horm. Metab. Res. 34, 212–216 (2002)

    Article  CAS  PubMed  Google Scholar 

  39. M. Lacroix, M.C. Battista, M. Doyon, J. Ménard, J.L. Ardilouze, P. Perron, M.F. Hivert, Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 36, 1577–1583 (2013)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. R. Retnakaran, Y. Qi, P.W. Connelly, M. Sermer, A.J. Hanley, B. Zinman, Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 53, 268–276 (2010)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. M.M. Hedderson, J. Darbinian, P.J. Havel, C.P. Quesenberry, S. Sridhar, S. Ehrlich, A. Ferrara, Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care 36, 3930–3937 (2013)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. M. Ballesteros, I. Simón, J. Vendrell, V. Ceperuelo-Mallafré, R.M. Miralles, G. Albaiges, F. Tinahones, A. Megia, Maternal and cord blood adiponectin multimeric forms in gestational diabetes mellitus: a prospective analysis. Diabetes Care 34, 2418–2423 (2011)

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. A. Borai, C. Livingstone, I. Kaddam, G. Ferns, Selection of the appropriate method for the assessment of insulin resistance. BMC Med. Res. Methodol. 11, 158 (2011)

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

All authors have no conflicts of interest to disclose, and this study was self-financed.

Author information

Affiliations

  1. Department of Endocrinology, Hebei Medical University, Shijiazhuang, China

    Xiaojiao Jia

  2. Department of Clinical Laboratory, The First Hospital of Qinhuangdao, Qinhuangdao, China

    Shuyi Wang

  3. Department of Endocrinology, The First Hospital of Qinhuangdao, No.258, Wenhua Road, Qinhuangdao, 066000, Hebei, China

    Xiaojiao Jia, Ning Ma, Xiaoli Liu & Qiang Lu

  4. Department of Obstetrics and Gynecology, The First Hospital of Qinhuangdao, Qinhuangdao, China

    Xiaojing Li & Likui Guo

  5. Department of Physical Examination Center, The First Hospital of Qinhuangdao, Qinhuangdao, China

    Tao Dong & Yali Liu

Authors
  1. Xiaojiao Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuyi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ning Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaojing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Likui Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaoli Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tao Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yali Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Qiang Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang Lu.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Jia, X., Wang, S., Ma, N. et al. Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women. Endocrine 48, 533–540 (2015). https://doi.org/10.1007/s12020-014-0318-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-014-0318-7

Keywords

  • Vaspin
  • Adipokines
  • Gestational diabetes mellitus
  • Homeostatic model assessment–insulin resistance